Total Payments
$1,164
2024 Payments
$18.77
Companies
15
Transactions
63
Medicare Patients
1,225
Medicare Billing
$135,790
Payment Breakdown by Category
Food & Beverage$1,164 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,164 | 63 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $485.34 | 38 | $0 (2024) |
| Inari Medical, Inc. | $188.90 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $137.97 | 2 | $0 (2020) |
| Gilead Sciences, Inc. | $59.31 | 5 | $0 (2018) |
| Insmed, Inc. | $56.88 | 4 | $0 (2022) |
| Edwards Lifesciences Corporation | $49.42 | 1 | $0 (2019) |
| Philips Electronics North America Corporation | $49.08 | 3 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $26.77 | 2 | $0 (2022) |
| Advanced Respiratory, Inc | $20.85 | 1 | $0 (2020) |
| Genentech USA, Inc. | $18.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.77 | 1 | GlaxoSmithKline, LLC. ($18.77) |
| 2023 | $108.39 | 7 | GlaxoSmithKline, LLC. ($78.25) |
| 2022 | $269.82 | 7 | Inari Medical, Inc. ($188.90) |
| 2021 | $12.91 | 1 | PFIZER INC. ($12.91) |
| 2020 | $98.66 | 6 | Insmed, Inc. ($33.06) |
| 2019 | $154.67 | 8 | GlaxoSmithKline, LLC. ($70.36) |
| 2018 | $201.29 | 17 | GlaxoSmithKline, LLC. ($149.98) |
| 2017 | $299.81 | 16 | AstraZeneca Pharmaceuticals LP ($124.99) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: RESPIRATORY | ||||||
| 08/25/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: IMMUNOLOGY | ||||||
| 02/16/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Inflammation | ||||||
| 02/09/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.24 | General |
| Category: Medical Device | ||||||
| 12/22/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Respiratory | ||||||
| 11/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Respiratory | ||||||
| 06/01/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $188.90 | General |
| Category: VTE | ||||||
| 04/28/2022 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Respiratory | ||||||
| 01/20/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: RESPIRATORY | ||||||
| 07/01/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/10/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Respiratory | ||||||
| 10/22/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Respiratory | ||||||
| 09/03/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Respiratory | ||||||
| 07/24/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: RESPIRATORY | ||||||
| 06/18/2020 | Advanced Respiratory, Inc | The Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Airway Clearance Device | ||||||
| 03/05/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: Dental and Oral Health | ||||||
| 12/05/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $16.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 250 | 316 | $73,036 | $22,977 |
| 2022 | 7 | 250 | 309 | $69,751 | $22,828 |
| 2021 | 9 | 335 | 437 | $118,782 | $39,858 |
| 2020 | 10 | 390 | 549 | $93,022 | $50,127 |
Total Patients
1,225
Total Services
1,611
Medicare Billing
$135,790
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 129 | $36,636 | $13,104 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 44 | $8,800 | $2,838 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $7,665 | $2,637 | 34.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 40 | 41 | $7,585 | $1,850 | 24.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 37 | 38 | $5,510 | $1,388 | 25.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 21 | 21 | $4,200 | $669.49 | 15.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 21 | 22 | $2,640 | $491.49 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 124 | $35,216 | $12,674 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 54 | $10,800 | $3,573 | 33.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 38 | 39 | $7,215 | $2,070 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,725 | $1,898 | 40.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 34 | 35 | $5,075 | $1,398 | 27.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 25 | 26 | $3,120 | $609.63 | 19.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 18 | 18 | $3,600 | $606.29 | 16.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 87 | 132 | $37,296 | $14,102 | 37.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 33 | 58 | $34,568 | $10,815 | 31.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 48 | $9,483 | $3,472 | 36.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,745 | $2,687 | 39.8% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 40 | 45 | $8,325 | $2,450 | 29.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 39 | $6,045 | $2,382 | 39.4% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 39 | 44 | $7,920 | $2,182 | 27.5% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 24 | 27 | $5,400 | $1,099 | 20.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 22 | 25 | $3,000 | $670.00 | 22.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 52 | 115 | $39,082 | $21,718 | 55.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 121 | $18,668 | $9,680 | 51.9% |
About Dr. Alan Pope, M.D
Dr. Alan Pope, M.D is a Pulmonary Disease healthcare provider based in Cherry Hill, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730160391.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Pope, M.D has received a total of $1,164 in payments from pharmaceutical and medical device companies, with $18.77 received in 2024. These payments were reported across 63 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,164).
As a Medicare-enrolled provider, Pope has provided services to 1,225 Medicare beneficiaries, totaling 1,611 services with total Medicare billing of $135,790. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Critical Care Medicine
- Location Cherry Hill, NJ
- Active Since 11/10/2005
- Last Updated 10/22/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1730160391
Products in Payments
- NUCALA (Biological) $228.10
- FLOWTRIEVER CATHETER, S (Device) $188.90
- BEVESPI AEROSPHERE (Drug) $124.99
- BREO (Drug) $111.45
- TRELEGY ELLIPTA (Drug) $77.30
- ANORO (Drug) $60.12
- Arikayce (Drug) $56.88
- (8874) inCourage (Device) $32.89
- The Vest System Model 105 Home Care (Device) $20.85
- Xolair (Biological) $18.70
- ZERBAXA (Drug) $17.09
- inCourage (Device) $16.19
- TEZSPIRE (Biological) $14.90
- AirDuo Digihaler (Drug) $14.48
- OPSUMIT MACITENTAN (Drug) $14.20
- FASENRA (Drug) $12.98
- ELIQUIS (Drug) $12.91
- CINQAIR (Drug) $12.29
- STIOLTO (Drug) $12.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Cherry Hill
Dr. Steven Baumgarten, M.d, M.D
Pulmonary Disease — Payments: $9,230
Pulmonary Disease $9,230
Ira Horowitz, M.d, M.D
Pulmonary Disease — Payments: $7,417
Pulmonary Disease $7,417
Dr. Nicholas Roy, D.o, D.O
Pulmonary Disease — Payments: $5,534
Pulmonary Disease $5,534
Dr. David Baumgarten, Md, MD
Pulmonary Disease — Payments: $4,680
Pulmonary Disease $4,680
Steffi Lena, D.o, D.O
Pulmonary Disease — Payments: $1,829
Pulmonary Disease $1,829
Dipakkumar Malli, Md, MD
Pulmonary Disease — Payments: $134.02
Pulmonary Disease $134.02